Companies › SYBX
SYNLOGIC INC (SYBX)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001527599 · EDGAR filings · Updated 2026-05-18
SYNLOGIC INC (SYBX) has reported institutional ownership of 0.2%, with 2 institutional managers holding positions valued at $14.5K per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.
Latest updates
- 2026-05-18 — 25-NSE filed
- 2026-05-14 — Quarterly report (10-Q) filed
- 2026-04-30 — 10-K/A filed
- 2026-04-06 — SCHEDULE 13D/A filed
- 2026-03-12 — Annual report (10-K) filed
- 2026-01-29 — Amended current report (8-K/A) filed
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, SYNLOGIC INC has 2 institutional holders and institutional ownership of 0.2%.
Insider activity
Insiders reported 4 transactions (0 buys, 2 sells) across 3 reporting insiders, with a net reported value of −$457.
Data flags from SEC filings
Related companies
CYTOMED THERAPEUTICS LIMITED (GDTC) · CHINA PHARMA HLDGS INC (CPHI) · BIOTRICITY INC (BTCY) · SciSparc Ltd (SPRC) · DECOY THERAPEUTICS INC COM (DCOY) · IM CANNABIS CORP (IMCC)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-05-18.